Cugene Inc.
PrivateLast Round
Growth Equity
May 1, 2024
Total Funding Raised
$48.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cugene Inc. operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Growth Equity round in May 2024.
Cugene Inc. is a biotechnology company developing next-generation medicines for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cugene Inc. Comparables
Compare Cugene Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nektar Therapeutics | 82% | |
| Egle Therapeutics | 80% | |
| GentiBio | 76% |
For institutional investors. Book with your work email.
Cugene Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | May 1, 2024 | ||||
| Corporate Funding | May 16, 2022 |
For institutional investors. Book with your work email.
Cugene Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Summer Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
Open roles increased to 4, 4x the trailing average.
- Jul 25, 2026
Monthly visitors increased 62% MoM, reaching 2.8K.
For institutional investors. Book with your work email.
Cugene Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cugene Inc.'s valuation, stock price, and market status.
Is Cugene Inc. a public or private company?
Cugene Inc. is a private company.
What is the current stock price of Cugene Inc.?
Cugene Inc. is a private company, so its shares have no public market price. Caplight tracks Cugene Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cugene Inc. worth (valuation)?
Valuation information for Cugene Inc. is not publicly available.
Can I buy Cugene Inc. stock?
Cugene Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cugene Inc.'s last funding round?
Cugene Inc.'s most recent funding round was Growth Equity on May 1, 2024.
Who are the main investors in Cugene Inc.?
Key investors in Cugene Inc. include Summer Capital.
Will Cugene Inc. IPO soon?
No public IPO plans have been announced for Cugene Inc..
How can I track Cugene Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Cugene Inc.'s shares on secondary markets.